257 related articles for article (PubMed ID: 30378540)
1. Prognostic factors and incidence of primary mucosal melanoma: a population-based study in France.
Beaudoux O; Riffaud L; Barbe C; Grange F
Eur J Dermatol; 2018 Oct; 28(5):654-660. PubMed ID: 30378540
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of 39 cases of pediatric cutaneous head and neck melanoma.
Tcheung WJ; Marcello JE; Puri PK; Abernethy AP; Nelson KC
J Am Acad Dermatol; 2011 Aug; 65(2):e37-e42. PubMed ID: 21075477
[TBL] [Abstract][Full Text] [Related]
3. Predictors of mucosal melanoma survival in a population-based setting.
Altieri L; Eguchi M; Peng DH; Cockburn M
J Am Acad Dermatol; 2019 Jul; 81(1):136-142.e2. PubMed ID: 30296542
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors and epidemiological characteristics of cutaneous and mucosal head and neck melanoma.
Berzina A; Azarjana K; Cema I; Pjanova D; Rivosh A
Stomatologija; 2011; 13(2):49-54. PubMed ID: 21822045
[TBL] [Abstract][Full Text] [Related]
5. Conjunctival malignant melanoma in Denmark: epidemiology, treatment and prognosis with special emphasis on tumorigenesis and genetic profile.
Larsen AC
Acta Ophthalmol; 2016 May; 94 Thesis 1():1-27. PubMed ID: 27192168
[TBL] [Abstract][Full Text] [Related]
6. Development of prognostic factors and survival in cutaneous melanoma over 25 years: An analysis of the Central Malignant Melanoma Registry of the German Dermatological Society.
Buettner PG; Leiter U; Eigentler TK; Garbe C
Cancer; 2005 Feb; 103(3):616-24. PubMed ID: 15630700
[TBL] [Abstract][Full Text] [Related]
7. Distribution of subsequent primary invasive melanomas following a first primary invasive or in situ melanoma Queensland, Australia, 1982-2010.
Youlden DR; Youl PH; Soyer HP; Aitken JF; Baade PD
JAMA Dermatol; 2014 May; 150(5):526-34. PubMed ID: 25093216
[TBL] [Abstract][Full Text] [Related]
8. Cutaneous malignant melanoma incidence and mortality trends in Canada: A comprehensive population-based study.
Ghazawi FM; Cyr J; Darwich R; Le M; Rahme E; Moreau L; Netchiporouk E; Zubarev A; Roshdy O; Glassman SJ; Sasseville D; Litvinov IV
J Am Acad Dermatol; 2019 Feb; 80(2):448-459. PubMed ID: 30092328
[TBL] [Abstract][Full Text] [Related]
9. Is head and neck melanoma a distinct entity? A clinical registry-based comparative study in 5702 patients with melanoma.
Hoersch B; Leiter U; Garbe C
Br J Dermatol; 2006 Oct; 155(4):771-7. PubMed ID: 16965427
[TBL] [Abstract][Full Text] [Related]
10. Is sex an independent prognostic factor in cutaneous head and neck melanoma?
Arce PM; Camilon PR; Stokes WA; Nguyen SA; Lentsch EJ
Laryngoscope; 2014 Jun; 124(6):1363-7. PubMed ID: 24122966
[TBL] [Abstract][Full Text] [Related]
11. The Growing Burden of Invasive Melanoma: Projections of Incidence Rates and Numbers of New Cases in Six Susceptible Populations through 2031.
Whiteman DC; Green AC; Olsen CM
J Invest Dermatol; 2016 Jun; 136(6):1161-1171. PubMed ID: 26902923
[TBL] [Abstract][Full Text] [Related]
12. [Prognostic factors of localized malignant melanoma: study of 639 patients].
Nagore Enguídanos E; Oliver Martínez V; Botella Estrada R; Insa Mollá A; Fortea Baixauli JM
Med Clin (Barc); 2005 Mar; 124(10):361-7. PubMed ID: 15766505
[TBL] [Abstract][Full Text] [Related]
13. Comparison of anatomical locations of cutaneous melanoma in men and women: a population-based study in France.
Chevalier V; Barbe C; Le Clainche A; Arnoult G; Bernard P; Hibon E; Grange F
Br J Dermatol; 2014 Sep; 171(3):595-601. PubMed ID: 24725117
[TBL] [Abstract][Full Text] [Related]
14. Variation in incidence and fatality of melanoma by season of diagnosis in new South Wales, Australia.
Boniol M; Armstrong BK; Doré JF
Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):524-6. PubMed ID: 16537711
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of S100/CD31 and S100/podoplanin double immunostaining in mucosal malignant melanoma of the head and neck.
Wermker K; Brauckmann T; Klein M; Haßfeld S; Schulze HJ; Hallermann C
Head Neck; 2015 Sep; 37(9):1368-74. PubMed ID: 24817089
[TBL] [Abstract][Full Text] [Related]
16. The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. The American College of Surgeons Commission on Cancer and the American Cancer Society.
Chang AE; Karnell LH; Menck HR
Cancer; 1998 Oct; 83(8):1664-78. PubMed ID: 9781962
[TBL] [Abstract][Full Text] [Related]
17. Clinical and sociodemographic characteristics associated with thick melanomas. A population-based, case-case study in France.
Grange F; Barbe C; Aubin F; Lipsker D; Granel-Brocard F; Velten M; Dalac S; Truchetet F; Michel C; Mitschler A; Arnoult G; Buemi A; Dalle S; Bernard P; Woronoff AS
Arch Dermatol; 2012 Dec; 148(12):1370-6. PubMed ID: 22986518
[TBL] [Abstract][Full Text] [Related]
18. Retrospective study on the cutaneous head and neck melanoma in Dorset (UK).
Komisarovas L; Jayasinghe C; Seah TE; Ilankovan V
Br J Oral Maxillofac Surg; 2011 Jul; 49(5):359-63. PubMed ID: 20678832
[TBL] [Abstract][Full Text] [Related]
19. Invasive cutaneous melanoma in The Netherlands, 1989-1990.
Tersmette AC; Coebergh JW; Casparie-van Velsen IJ; Ruiter DJ; van der Rhee HJ; Welvaart K
Eur J Cancer Prev; 1996 Feb; 5(1):69-74. PubMed ID: 8664813
[TBL] [Abstract][Full Text] [Related]
20. Melanoma staging: Varying precision and terminal digit clustering in Breslow thickness data is evident in a population-based study.
Veierød MB; Page CM; Aaserud S; Bassarova A; Jacobsen KD; Helsing P; Robsahm TE
J Am Acad Dermatol; 2018 Jul; 79(1):118-125.e1. PubMed ID: 29580861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
